Skip to content

Price / book at other companies

Schrodinger logo
SchrodingerSDGR
2.7×-1.2×
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
1.6×-0.7×
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
5.9×+3.9×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
1.1×+0.5×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
125.1×+108×
ADMA Biologics logo
ADMA BiologicsADMA
5.5×-7.1×

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Calculated from Absci Corporation’s reported figures.

Based on the most recent quarter.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's price / book?
Absci Corporation (ABSI) reported price / book of 2.7× in Q1 2026.
How has Absci Corporation's price / book changed year-over-year?
Absci Corporation's price / book increased by 66.0% year-over-year, from 1.6× to 2.7×.
What is the long-term trend for Absci Corporation's price / book?
Over 4 years (2021 to 2025), Absci Corporation's price / book has grown at a 7.5% compound annual growth rate (CAGR), from 2.1× to 2.8×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.